RX BENCHMARKS Trademark

Trademark Overview

On Tuesday, January 21, 2020, a trademark application was filed for RX BENCHMARKS with the United States Patent and Trademark Office. The USPTO has given the RX BENCHMARKS trademark a serial number of 88767347. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by PROTEAN LLC. The RX BENCHMARKS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Marketing research and analysis services in the field of biopharmaceuticals; business services, namely, providing logistics analysis information in the field of pharmaceutical market access management
rx benchmarks

General Information

Serial Number88767347
Word MarkRX BENCHMARKS
Filing DateTuesday, January 21, 2020
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6241850
Registration DateTuesday, January 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkRX BENCH MARKS
Goods and ServicesMarketing research and analysis services in the field of biopharmaceuticals; business services, namely, providing logistics analysis information in the field of pharmaceutical market access management

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code035
First Use Anywhere DateFriday, March 6, 2020
First Use In Commerce DateFriday, March 6, 2020

Trademark Owner History

Party NamePROTEAN LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRaleigh, NC 27615
Party NamePROTEAN LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRaleigh, NC 27615

Trademark Events

Event DateEvent Description
Friday, January 24, 2020NEW APPLICATION ENTERED
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Wednesday, April 15, 2020NON-FINAL ACTION WRITTEN
Wednesday, April 15, 2020NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 6, 2020FINAL REFUSAL WRITTEN
Friday, November 6, 2020FINAL REFUSAL E-MAILED
Friday, November 6, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 23, 2020TEAS AMENDMENT OF USE RECEIVED
Tuesday, November 24, 2020USE AMENDMENT FILED
Tuesday, November 24, 2020AMENDMENT TO USE PROCESSING COMPLETE
Monday, November 23, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 1, 2020USE AMENDMENT ACCEPTED
Tuesday, December 1, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, December 2, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, December 2, 2020ASSIGNED TO LIE
Wednesday, December 2, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 5, 2021REGISTERED-SUPPLEMENTAL REGISTER
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

benchmarks services analysis field pharmaceutical information market access logistics management namely